Monopar Therapeutics MNPR
NASDAQ MNPR
$73.75 +2.33 (+3.26%)
At close: Nov 9, 2026 · 4:00 PM EST

Monopar Therapeutics (MNPR) Other Non Operating Income (2024 - 2026)

Updated

Monopar Therapeutics (MNPR) recorded Other Non Operating Income of $32,158 in Q2 2026.

Analysis

Monopar Therapeutics (MNPR) Other Non Operating Income (2024 - 2026) Analysis & Trends

On a TTM basis, Monopar Therapeutics' Other Non Operating Income came in at $203,440 as of Jun 30, 2026.

  • The Q2 2026 figure is the highest quarterly Other Non Operating Income since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Monopar Therapeutics 630.69 Mn 335.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32,158.00
Sep 30, 2024 171,282.00
API Access

Monopar Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=MNPR&period=max&api_key=YOUR_API_KEY